A randomized clinical trial comparing the effect of different haemostatic agents for haemostasis of the liver after hepatic resection.

Conclusion. Due to higher complications in Surgicel group, its application as hemostatic agent after liver resection is not recommended. Better results in TachoSil in comparison to the other two are indicative of its better efficacy and superiority in controlling hemostasis. PMID: 24159254 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/24159254?dopt=Abstract

Source: HPB Surgery - October 29, 2015 Category: Surgery Tags: HPB Surg Source Type: research